From Rs 6.27 to Rs 30.38 per share: Pharma company received certificate of recognition, One Star Export House from Government of India From Rs 6.27 to Rs 30.38 per share: Pharma company received certificate of recognition, One Star Export House from Government of India The stock gave multibagger returns of 385 per cent from its 52-week low of Rs 6.27 per share. DSIJ Intelligence-1 / Thursday, June 5, 2025 0 148 Article rating: 3.8 The stock gave multibagger returns of 385 per cent from its 52-week low of Rs 6.27 per share. Read more
Pharma Penny Stock Under Rs 50 Approves FY25 Audited Results; Recommended Rs 0.10 Dividend & Approves Rs 37.22 Cr Acquisition in Trimax Bio Sciences Pharma Penny Stock Under Rs 50 Approves FY25 Audited Results; Recommended Rs 0.10 Dividend & Approves Rs 37.22 Cr Acquisition in Trimax Bio Sciences From Rs 34.51 per share (52-week low) to Rs 53.59 per share, the stock is up by 55.3 per cent. DSIJ Intelligence-1 / Monday, June 2, 2025 0 264 Article rating: 4.0 From Rs 34.51 per share (52-week low) to Rs 53.59 per share, the stock is up by 55.3 per cent. Read more
Low PE pharma penny stock below Rs 60 jumps 14.50 per cent after reporting turnaround net profit of Rs 25 crore in FY25 Low PE pharma penny stock below Rs 60 jumps 14.50 per cent after reporting turnaround net profit of Rs 25 crore in FY25 The company has a market cap of over Rs 300 crore and the stock is up by 16.34 per cent from its 52-week low of Rs 49.20 per share. DSIJ Intelligence-1 / Monday, June 2, 2025 0 240 Article rating: 3.4 The company has a market cap of over Rs 300 crore and the stock is up by 16.34 per cent from its 52-week low of Rs 49.20 per share. Read more
40 Per Cent Returns from 52-Week Low; Board Announce 1:1 Bonus Shares and 30 Per Cent Dividend 40 Per Cent Returns from 52-Week Low; Board Announce 1:1 Bonus Shares and 30 Per Cent Dividend The stock is up over 40 per cent from its 52-week low of Rs 148.05 per share. DSIJ Intelligence-1 / Sunday, May 25, 2025 0 734 Article rating: 3.6 The stock is up over 40 per cent from its 52-week low of Rs 148.05 per share. Read more
2:1 Stock Split: Gujarat-Based Penny Stock Under Rs 2 Hit Upper Circuits as PAT Jumps 14,940 Per Cent in FY25 2:1 Stock Split: Gujarat-Based Penny Stock Under Rs 2 Hit Upper Circuits as PAT Jumps 14,940 Per Cent in FY25 The stock is trading at 0.65 times its book value and the stock is up by 36 per cent from its 52-week low of Rs 1.04 per share. DSIJ Intelligence-1 / Friday, May 23, 2025 0 465 Article rating: 4.2 The stock is trading at 0.65 times its book value and the stock is up by 36 per cent from its 52-week low of Rs 1.04 per share. Read more
47 Per Cent Returns from 52-Week Low; Board Likely to Announce Bonus Shares and Dividend 47 Per Cent Returns from 52-Week Low; Board Likely to Announce Bonus Shares and Dividend The stock is up by 47 per cent from its 52-week low of Rs 148.05 per share. DSIJ Intelligence-1 / Tuesday, May 20, 2025 0 254 Article rating: 4.5 The company has a market cap of over Rs 1,000 crore and has delivered good profit growth of 19 per cent CAGR over the last 5 years with a healthy dividend payout of 26 per cent. Read more
CuraTeQ Biologics receives approval for Biosimilar Zefylti from the UK’s MHRA CuraTeQ Biologics receives approval for Biosimilar Zefylti from the UK’s MHRA The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 52-week low of Rs 994.35 per share. DSIJ Intelligence-1 / Wednesday, May 14, 2025 0 143 Article rating: 5.0 The company has a market cap of over Rs 70,000 crore and the stock is up by 24.3 per cent from its 52-week low of Rs 994.35 per share. Read more
Multibagger Pharma Stock Under Rs 50 To Be in Focus Today as Company Acquires 100 Per Cent Stake in Cibachem General Trading L.L.C Multibagger Pharma Stock Under Rs 50 To Be in Focus Today as Company Acquires 100 Per Cent Stake in Cibachem General Trading L.L.C The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share. DSIJ Intelligence-1 / Wednesday, May 14, 2025 0 630 Article rating: 4.0 The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share. Read more
From Rs 5.83 to Rs 29.69 Per Share in Just 11 Months & 10 Days: Multibagger Pharma Stock Hit Upper Circuit for Second Straight Day From Rs 5.83 to Rs 29.69 Per Share in Just 11 Months & 10 Days: Multibagger Pharma Stock Hit Upper Circuit for Second Straight Day The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share. DSIJ Intelligence-1 / Tuesday, May 13, 2025 0 584 Article rating: 3.7 The stock gave multibagger returns of over 400 per cent from its 52-week low of Rs 5.82 per share. Read more
Promoters hold 66 per cent stake: Pharma penny stock jumps 8.5 per cent; Do You Own It? Promoters hold 66 per cent stake: Pharma penny stock jumps 8.5 per cent; Do You Own It? The company has a market cap of over Rs 300 crore and the stock is up by 12.4 per cent from its 52-week low of Rs 50.42 per share. DSIJ Intelligence-1 / Monday, May 12, 2025 0 307 Article rating: 4.5 The shares of the company have a PE of 12x whereas the industry PE is 30x. Read more
Pharma Penny Stock Below Rs 20: Company Receives Order Worth Rs 12,59,50,000 from J D Healthcare Pharma Penny Stock Below Rs 20: Company Receives Order Worth Rs 12,59,50,000 from J D Healthcare The stock is up by 44 per cent from its 52-week low of Rs 12.33 per share. DSIJ Intelligence-1 / Monday, May 12, 2025 0 548 Article rating: 4.1 The stock is up by 44 per cent from its 52-week low of Rs 12.33 per share. Read more
Pharma Penny Stock Under Rs 50 Jumps After Company Successfully Achieved Certificate of Suitability (CEP) for Metformin Hydrochloride from European Directorate Pharma Penny Stock Under Rs 50 Jumps After Company Successfully Achieved Certificate of Suitability (CEP) for Metformin Hydrochloride from European Directorate From Rs 34.51 per share (52-week low) to Rs 41.39 per share, the stock is up by 20 per cent. . DSIJ Intelligence-1 / Wednesday, May 7, 2025 0 520 Article rating: 4.4 From Rs 34.51 per share (52-week low) to Rs 41.39 per share, the stock is up by 20 per cent. . Read more
Multibagger Pharma Stock Under Rs 30: Company Reports a 45 Per Cent Jump in PAT & FIIs Bought 1,29,48,000 Shares Multibagger Pharma Stock Under Rs 30: Company Reports a 45 Per Cent Jump in PAT & FIIs Bought 1,29,48,000 Shares The stock gave multibagger returns of 358 per cent from its 52-week low of Rs 5.82 per share. DSIJ Intelligence-1 / Sunday, May 4, 2025 0 898 Article rating: 4.2 The stock gave multibagger returns of 358 per cent from its 52-week low of Rs 5.82 per share. Read more
Penny Stock Below Rs 5: Board to Raise Capital, Acquire Controlling Stakes in Two Firms via Share Swap and Expand Business Scope Penny Stock Below Rs 5: Board to Raise Capital, Acquire Controlling Stakes in Two Firms via Share Swap and Expand Business Scope The stock is up by 57 per cent from its 52-week low of Rs 2.11 per share. DSIJ Intelligence-1 / Wednesday, April 30, 2025 0 558 Article rating: 4.5 The stock is up by 57 per cent from its 52-week low of Rs 2.11 per share. Read more
Pharma Penny Stock Under Rs 50 In Green After Signing MoU with Respilon Group s.r.o Pharma Penny Stock Under Rs 50 In Green After Signing MoU with Respilon Group s.r.o From Rs 34.51 per share (52-week low) to Rs 43.93 per share, the stock is up by 27.3 per cent. DSIJ Intelligence-1 / Monday, April 28, 2025 0 256 Article rating: 4.0 From Rs 34.51 per share (52-week low) to Rs 43.93 per share, the stock is up by 27.3 per cent. Read more
Pharma Company Bags New Rs 44 Crore Order From United Nations International Children's Emergency Fund (UNICEF) Pharma Company Bags New Rs 44 Crore Order From United Nations International Children's Emergency Fund (UNICEF) The company has a market cap of over Rs 3,000 crore and the stock gave multibagger returns of 382 per cent from its 52-week low of Rs 112.35 per share. DSIJ Intelligence-1 / Thursday, April 24, 2025 0 370 Article rating: 3.6 The company has a market cap of over Rs 3,000 crore and the stock gave multibagger returns of 382 per cent from its 52-week low of Rs 112.35 per share. Read more
Eugia Pharma receives USFDA Approval for Dasatinib Tablets Eugia Pharma receives USFDA Approval for Dasatinib Tablets The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-week low of Rs 994.35 per share. DSIJ Intelligence-1 / Wednesday, April 23, 2025 0 282 Article rating: 5.0 The company has a market cap of over Rs 70,000 crore and the stock is up by 23 per cent from its 52-week low of Rs 994.35 per share. Read more
Pharmaceuticals Company Gets USFDA Approval For Phytonadione Injectable Emulsion Pharmaceuticals Company Gets USFDA Approval For Phytonadione Injectable Emulsion The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years. DSIJ Intelligence-1 / Wednesday, April 23, 2025 0 376 Article rating: 4.2 The stock gave multibagger returns of 190 per cent in 2 years and a whopping 500 per cent in 5 years. Read more
Kiran Mazumdar Shaw-Backed Pharma Company is Likely to Raise Funds by Way of Issue of Equity Shares Kiran Mazumdar Shaw-Backed Pharma Company is Likely to Raise Funds by Way of Issue of Equity Shares The company has been maintaining a healthy dividend payout of 18 per cent. DSIJ Intelligence-1 / Sunday, April 20, 2025 0 524 Article rating: 3.7 The company has a market cap of Rs 39,728 crore where Kiran Mazumdar Shaw (promoter of the company) holds a 40.36 per cent stake in the company. Read more
Pharma Company Has Received Final Approval From United States Food and Drug Administration For Abbreviated New Drug Application Pharma Company Has Received Final Approval From United States Food and Drug Administration For Abbreviated New Drug Application The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-week low of Rs 1,310.05 per share. DSIJ Intelligence-1 / Sunday, April 13, 2025 0 500 Article rating: 4.7 The company has a market cap of over Rs 1 lakh crore and the stock is up by 13 per cent from its 52-week low of Rs 1,310.05 per share. Read more
Pharma Penny Stock Under Rs 60: Company Set For Bold Expansion; To Add 1000 Medical Representatives Pharma Penny Stock Under Rs 60: Company Set For Bold Expansion; To Add 1000 Medical Representatives The company has a market cap of over Rs 2,750 crore and the stock is up over 20 per cent from its 52-week low of Rs 41.66 per share DSIJ Intelligence-1 / Saturday, April 12, 2025 0 571 Article rating: 3.4 The company has a market cap of over Rs 2,750 crore and the stock is up over 20 per cent from its 52-week low of Rs 41.66 per share Read more
Pharma Company Bags Order Worth Rs 150-180 Million From Tamil Nadu Medical Services Corporation Pharma Company Bags Order Worth Rs 150-180 Million From Tamil Nadu Medical Services Corporation The company has a market cap of over Rs 300 crore and the stock is up by 1.6 per cent from its 52-week low of Rs 635 per share. DSIJ Intelligence-1 / Friday, April 11, 2025 0 207 Article rating: 4.7 The company has a market cap of over Rs 300 crore and the stock is up by 1.6 per cent from its 52-week low of Rs 635 per share. Read more
Pharma Company Expands Capabilities with New Peptide Research Center Pharma Company Expands Capabilities with New Peptide Research Center The company's Price-Earnings (PE) Ratio stands at 165.54. DSIJ Intelligence-1 / Saturday, April 5, 2025 0 273 Article rating: 3.9 Major public shareholders include Tpg Asia Vii Sf Pte Ltd with 24.78 per cent, HBM Private Equity India with 1.99 per cent, Anitha Rudraraju Nandyala with 1.73 per cent, Raju Penmasta with 1.11 per cent and Penmasta Aruna with 1.02 per cent. Read more
Pharma Company Enters Into Share Purchase Agreement and Power Supply Agreement with Torrent Urja 19 Pvt Ltd Pharma Company Enters Into Share Purchase Agreement and Power Supply Agreement with Torrent Urja 19 Pvt Ltd The company has a market cap of over Rs 13,000 crore and the stock is up 45 per cent from its 52-week low of Rs 743.60 per share. DSIJ Intelligence-1 / Thursday, April 3, 2025 0 271 Article rating: 4.5 The company has a market cap of over Rs 13,000 crore and the stock is up 45 per cent from its 52-week low of Rs 743.60 per share. Read more
Pharma Penny Stock Under Rs 50 Jumps Over 5 Per Cent on April 03; Do you Have It? Pharma Penny Stock Under Rs 50 Jumps Over 5 Per Cent on April 03; Do you Have It? From Rs 34 per share (52-week low) to Rs 38.90 per share, the stock is up by 14.4 per cent. DSIJ Intelligence-1 / Thursday, April 3, 2025 0 413 Article rating: 4.5 From Rs 34 per share (52-week low) to Rs 38.90 per share, the stock is up by 14.4 per cent. Read more
46 Per Cent Returns From 52-Week Low: Pharma Stock Under Rs 75, Hit 10 Per Cent Upper Circuit; Here’s Why 46 Per Cent Returns From 52-Week Low: Pharma Stock Under Rs 75, Hit 10 Per Cent Upper Circuit; Here’s Why The company has a market cap of over Rs 400 crore and the stock is up by 46 per cent from its 52-week low of Rs 50.42 per share. DSIJ Intelligence-1 / Thursday, April 3, 2025 0 226 Article rating: 5.0 The company has a market cap of over Rs 400 crore and the stock is up by 46 per cent from its 52-week low of Rs 50.42 per share. Read more
Multibagger Pharma Company Expands into New Territory with Innovative Pediatric Solution Multibagger Pharma Company Expands into New Territory with Innovative Pediatric Solution The stock has delivered 85 per cent in 1 year and gave multibagger returns of 240 per cent in 2 years. DSIJ Intelligence-1 / Saturday, March 22, 2025 0 232 Article rating: 5.0 The stock has delivered 85 per cent in 1 year and gave multibagger returns of 240 per cent in 2 years. Read more
Pharma Giant Expands with Strategic Acquisition in Singapore Pharma Giant Expands with Strategic Acquisition in Singapore The company has a strong presence in regulated markets such as the United States and Europe and is a leading producer of niche generic formulations. DSIJ Intelligence-1 / Thursday, March 20, 2025 0 297 Article rating: 4.0 The company has been actively expanding its product pipeline, with over 70 commercialized products and a healthy pipeline of 100+ approved products. Read more
42.4% Returns From 52-Week Low: Pharma Stock Under Rs 75 Jumps 19.9%; Do You Own It? 42.4% Returns From 52-Week Low: Pharma Stock Under Rs 75 Jumps 19.9%; Do You Own It? The company has a market cap of over Rs 380 crore and the stock is up by 42.4 per cent from its 52-week low of Rs 50.42 per share. DSIJ Intelligence-1 / Friday, March 7, 2025 0 261 Article rating: 5.0 The company has a market cap of over Rs 380 crore and the stock is up by 42.4 per cent from its 52-week low of Rs 50.42 per share. Read more
Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares Pharma stock under Rs 70 jumps 11.5%; Unico Global Opportunities Fund bought 45,77,717 shares & Ebisu Global Opportunities Fund bought 45,21,028 shares The company has a market cap of over Rs 300 crore and the stock is up by 24.1 per cent from its 52-week low of Rs 50.42 per share. DSIJ Intelligence-1 / Wednesday, March 5, 2025 0 405 Article rating: 5.0 The company has a market cap of over Rs 300 crore and the stock is up by 24.1 per cent from its 52-week low of Rs 50.42 per share. Read more
Pharma penny stock under Rs 35 in green after acquiring 10,000 shares of its Singapore subsidiary Pharma penny stock under Rs 35 in green after acquiring 10,000 shares of its Singapore subsidiary The stock gave multibagger returns of 467 per cent from its 52-week low of Rs 5.82 per share. DSIJ Intelligence-1 / Thursday, February 27, 2025 0 331 Article rating: 4.0 The stock gave multibagger returns of 467 per cent from its 52-week low of Rs 5.82 per share. Read more
Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC Pharma penny stock under Rs 60 in green after bagging new order worth USD 23,000 from FIRSTVET Veterinary Medicines Trading LLC The stock is up 40.14 per cent from its 52-week low of Rs 41.10 per share. DSIJ Intelligence-1 / Thursday, December 26, 2024 0 392 Article rating: 3.9 The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. Read more
Pharma Penny Stock Under Rs 60 In Green After Bagging A Significant New Order Worth Rs 6,28,15,000 Pharma Penny Stock Under Rs 60 In Green After Bagging A Significant New Order Worth Rs 6,28,15,000 The company has a market cap of Rs 63 crore and on Tuesday, the stock was trading at Rs 53.80 per share on NSE. DSIJ Intelligence-1 / Tuesday, November 19, 2024 0 385 Article rating: 4.0 The company has a market cap of Rs 63 crore and on Tuesday, the stock was trading at Rs 53.80 per share on NSE. Read more
Pharma penny stock under Rs 55 in green as company bags new order worth USD 19,200 from Genet International & FIRSTVET Veterinary Medicines Trading LLC Pharma penny stock under Rs 55 in green as company bags new order worth USD 19,200 from Genet International & FIRSTVET Veterinary Medicines Trading LLC The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. DSIJ Intelligence-1 / Wednesday, October 30, 2024 1 1140 Article rating: 3.5 The stock is up 34.21 per cent from its 52-week low of Rs 38.01 per share. Read more
Penny stock below Rs 50 jumps over 10 per cent as pharma company bags new order worth USD 17,700 from Al-Saqr Agro For Agricultural And Veterinary Entries Penny stock below Rs 50 jumps over 10 per cent as pharma company bags new order worth USD 17,700 from Al-Saqr Agro For Agricultural And Veterinary Entries The shares of the company have an ROE of 25 per cent and an ROCE of 32 per cent. DSIJ Intelligence-1 / Thursday, September 19, 2024 0 627 Article rating: 3.9 The stock is up 30 per cent from its 52-week low of Rs 37.50 per share. Read more
230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it? 230 per cent returns: This multibagger pharmaceutical company announced approval for a new drug from US FDA; do you own it? The company has delivered returns of 14.5 per cent over the past 3 years and returns of 230 per cent over the past 5 years. DSIJ Intelligence / Friday, July 14, 2023 0 14507 Article rating: 4.1 The company has a ROCE of 19.4 per cent and a ROE of 19.1 per cent. Read more
This innovative Pharma company launches Thiamine Hydrochloride Injection USP in the United States! This innovative Pharma company launches Thiamine Hydrochloride Injection USP in the United States! The company holds a leadership position in cardiovascular, anti-diabetic and respiratory segments and is the third-largest pharmaceutical company in the U.S. by prescriptions. DSIJ Intelligence / Monday, June 19, 2023 0 429 Article rating: 4.0 A global pharmaceutical company, has announced the launch of Thiamine Hydrochloride Injection USP, following the approval of its alliance partner Caplin Steriles Limited's ANDA by the U.S. FDA. Read more
Biggest IPO of 2023 gets listed; stock surges 31.86 per cent from issue price Biggest IPO of 2023 gets listed; stock surges 31.86 per cent from issue price IPO listed with a 20.37 per cent premium on the BSE! DSIJ Intelligence / Tuesday, May 9, 2023 0 1596 Article rating: 4.5 IPO listed with a 20.37 per cent premium on the BSE! Read more
Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results! Upper Circuit: This micro-cap pharma stock reported stellar Q3FY23 results! In an aim to expand their product portfolio, the company is focusing on developing multiple manufacturing sites DSIJ Intelligence / Monday, January 30, 2023 0 515 Article rating: 3.7 They initiated contract manufacturing from three new locations this quarter and with this, they are currently manufacturing at nine locations across India Read more
Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it? Only buyers: Shares of this pharmaceutical company are locked at 20 per cent upper circuit. Do you own it? This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness. DSIJ Intelligence-1 / Tuesday, November 15, 2022 0 3245 Article rating: 4.3 This stock is currently available at a PE multiple of 21.47 and an ROE of 9.68, all of which indicate good management effectiveness. Read more
Shilpa Medicare skyrockets by 10.47 per cent on a weak market day! Shilpa Medicare skyrockets by 10.47 per cent on a weak market day! The board of the company also has recommended a dividend of Rs 1.10 per equity share for the financial year ended March 31, 2022.  DSIJ Intelligence / Tuesday, May 24, 2022 0 591 Article rating: 5.0 The shares of Shilpa Medicare soared 10.47 per cent to Rs 453.25 on BSE after the company announced promising results for the quarter that ended on March 31, 2022. Read more